AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on Non-Volatile Nanomagnetic Semiconductor Architecture
Hoth Therapeutics (NASDAQ:HOTH) plans to change its name to Rocket One and refocus on AI semiconductor infrastructure, ultra-low-power AI computing, and spintronic technologies while placing its biotechnology assets in a wholly owned subsidiary.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Hoth Therapeutics (NASDAQ:HOTH) plans to change its name to Rocket One and refocus on AI semiconductor infrastructure, ultra-low-power AI computing, and spintronic technologies while placing its biotechnology assets in a wholly owned subsidiary.
The company obtained exclusive rights to a non-volatile nanomagnetic matrix multiplier AI accelerator and a spintronic memory platform from VCU, targeting AI data center power demands, defense, aerospace, and space-based computing applications.
Positive
- Exclusive licenses to nanomagnetic matrix multiplier AI accelerator technology
- Exclusive rights to spintronic memory platform for advanced computing
- Strategic pivot into AI semiconductor infrastructure and ultra-low-power AI computing
- Plan to retain biotechnology portfolio value in a wholly owned subsidiary
- Board of Directors unanimously approved the business refocusing and restructuring
Negative
- None.
Details
News Market Reaction – HOTH
On May 19, the day this news came out, HOTH closed 2.07% below the previous close.
Data tracked by StockTitan Argus for the May 19 session.
Key Figures
- Quarterly net loss
- $2.7 million
- Most recent 10-Q; improved from about $3.5 million year-over-year
- R&D expenses
- $1.5 million
- Most recent quarter per 10-Q, down year-over-year
- G&A expenses
- $1.1 million
- Most recent quarter per 10-Q, down year-over-year
- Cash and equivalents
- $4.0 million
- Balance as of March 31, 2026 per 10-Q
- Accumulated deficit
- $75.6 million
- As of March 31, 2026 per 10-Q
- ATM capacity
- $1,555,000
- Aggregate offering price under April 16, 2026 424B5 at-the-market program
- Shelf registration size
- $50 million
- Maximum primary offering amount under Form S-3 shelf filed November 14, 2025
- Short float
- 30.8%
- Reported short interest as share of float; days to cover 1
Historical Context
-
HT-001 Phase 2a CLEER interim data and Spain authorization drove upside reaction.
-
HT-VA preclinical data showing favorable liver fat metabolism effects vs semaglutide.
-
Initial HT-VA CRADA preclinical release on GDNF-driven liver fat metabolism changes.
-
Closing of $2.0M registered direct and warrants, yet shares rose slightly afterward.
-
$2.0M registered direct and warrants announcement coincided with a sharp selloff.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
non-volatile nanomagnetic semiconductor architecture technical
spintronic computing technologies technical
matrix multiplier technical
spintronic memory technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company Targets Power Demands of AI Data Centers Through Patented Nanomagnetic Semiconductor and Spintronic Computing Technologies for AI, Defense, and Space Applications
Under its soon to be newly rebranded name, Rocket One, Inc., and the newly obtained licenses, the Company will enter the expanding AI semiconductor market, with exclusive rights to AI Semiconductor Acceleration Technology Built on Non-Volatile Nanomagnetic Semiconductor Architecture and to spintronic computing technologies developed at Virginia Commonwealth University ("VCU") targeting one of the largest challenges facing artificial intelligence today: power consumption and computing efficiency.
The Company intends to continue its biotechnology programs and is exploring placing its biotechnology assets in a separate, wholly owned subsidiary.
The refocusing of the business was unanimously approved by the Company's Board of Directors. Additional details regarding the licenses and proposed business will be included in a Current Report on Form 8-K that will be filed timely with the Securities and Exchange Commission.
AI Infrastructure Is Reaching a Breaking Point
Artificial intelligence has become the defining workload of modern computing, driving an unprecedented global buildout of AI data centers, autonomous systems, edge AI infrastructure, and high-performance computing environments.
But the AI industry is increasingly constrained by:
- escalating power consumption
- cooling limitations
- memory bottlenecks
- inference latency
- rising infrastructure costs
As demand for large language models, generative AI, and autonomous systems accelerates globally, the world's largest technology companies are actively searching for next-generation semiconductor architectures capable of delivering dramatically improved efficiency beyond conventional silicon approaches.
The Company believes solving these infrastructure constraints represents one of the most significant opportunities in the future of artificial intelligence.
Exclusive AI Semiconductor and Spintronic Computing Portfolio
Rocket One has secured exclusive rights to what it believes are two complementary spintronic semiconductor technologies. And
Nanomagnetic Matrix Multiplier — AI Hardware Acceleration
The Company secured exclusive rights to
"A compact, low-energy, non-volatile nanomagnetic matrix multiplier as a hardware accelerator for machine learning and artificial intelligence."
Matrix multiplication is the foundational operation underlying virtually all modern AI workloads, including transformer architectures powering large language models and generative artificial intelligence systems.
The licensed architecture is designed to support:
- ultra-low-power AI acceleration
- next-generation AI inference
- advanced memory efficiency
- edge AI systems
- intelligent autonomous platforms
- distributed AI infrastructure
The second technology utilizes electron spin rather than conventional charge-based semiconductor approaches and is intended to address growing energy efficiency constraints in AI computing infrastructure.
Spintronic Memory Platform — Defense, Autonomous Systems, and Space Computing
Rocket One secured exclusive rights to spintronic memory technologies designed for advanced computing and information processing applications with potential relevance to:
- radiation-tolerant computing
- defense infrastructure
- autonomous aerospace systems
- resilient edge compute
- orbital AI environments
- next-generation intelligent systems
The Company believes the same underlying spintronic physics supporting AI acceleration may also provide long-term opportunities across defense and space-based computing infrastructure markets.
Building an AI Infrastructure Platform
The Company intends to pursue a capital-efficient growth strategy focused on:
- semiconductor infrastructure partnerships
- AI hardware commercialization
- sponsored research
- strategic acquisitions
- defense and aerospace opportunities
- advanced compute infrastructure
- intelligent edge systems
The Company also plans to expand leadership with expertise spanning:
- semiconductor operations
- AI infrastructure
- advanced computing architectures
- defense technologies
- high-performance computing
Management Commentary
"Artificial intelligence is rapidly transforming every major industry, but the infrastructure powering AI is approaching critical energy and efficiency limits," said Robb Knie, Chief Executive Officer.
"We believe next-generation semiconductor architectures capable of dramatically improving power efficiency, memory performance, and intelligent computing scalability represent one of the largest opportunities in global technology today. Rocket One is being built to position the Company to participate in the future of AI infrastructure."
Biotechnology Operations Continue Under Subsidiary Structure
The Company 's is exploring placing its biotechnology pipeline and therapeutic development programs under a separate, wholly owned subsidiary with dedicated management and operational resources. The restructuring is intended to preserve the value of the biotechnology portfolio for shareholders while enabling the parent company to pursue emerging opportunities in AI semiconductor infrastructure and advanced computing technologies.
About Rocket One, Inc.
Rocket One Inc. is focused on the development and commercialization of spintronic computing technologies for artificial intelligence hardware acceleration and radiation-tolerant computing applications. The Company holds exclusive rights to technologies licensed for nanomagnetic matrix multiplier architecture designed as a hardware accelerator for machine learning and artificial intelligence workloads, and a skyrmion-based spintronic memory technology with potential applications in radiation-tolerant computing for defense and space systems.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the Company's corporate restructuring, strategic direction, the development potential of the licensed technologies, anticipated future operations, planned hires, planned acquisitions, planned research relationships, and the market opportunities described herein. These forward-looking statements are based on the Company's current expectations and assumptions and are subject to numerous risks and uncertainties. Risks include, without limitation: the early-stage nature of the licensed technologies and the absence of any commercial product; the substantial additional capital the Company will require to execute its strategic plan; the Company's ability to raise such capital on acceptable terms or at all; competition from larger and better-funded companies in the semiconductor, AI hardware, and defense computing sectors; the Company's ability to recruit and retain qualified leadership and technical personnel; the Company's ability to identify, finance, and complete strategic acquisitions on acceptable terms; the Company's ability to comply with diligence milestones under the VCU license agreements, the failure of which could result in loss of license rights; intellectual property risks, including that one of the licensed patents is a patent application that has not yet issued and may issue, if at all, with claims narrower than currently sought; government use rights and other limitations on the licensed technologies arising from federal research funding under the Bayh-Dole Act; uncertainties in the demand for spintronic computing solutions; the risks of operating in a regulated industry; and the risks inherent in a corporate restructuring, including those affecting the Company's existing biotechnology operations and shareholder base.
Additional risk factors are described in the Company's filings with the Securities and Exchange Commission, including the Form 8-K filed concurrently with this press release and the Company's most recent Annual Report on Form 10-K and subsequent quarterly reports. Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update such statements except as required by law.
Investor Contact:
LR Advisors LLC
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791
View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-chip-energy-efficiency-hoth-therapeutics-restructures-as-rocket-one-inc-to-enter-the-ai-semiconductor-infrastructure-market-with-acquisition-of-exclusive-rights-to-next-generation-ai-semiconductor-acceleration-technology-buil-302776054.html
SOURCE Hoth Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.